Question 1

Has Nirupama Krishnamurthi received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $11,593 in general payments to Nirupama Krishnamurthi across 160 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Nirupama Krishnamurthi did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Nirupama Krishnamurthi come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Abbott	27	$3,840
Biosense Webster, Inc.	20	$2,451
Medtronic	32	$2,311
Abiomed	14	$917
Boston Scientific	7	$480
Actelion Pharmaceuticals US, Inc.	9	$296
Angiodynamics, Inc.	1	$197
Novartis	15	$178
Inari Medical, Inc.	1	$176
Amgen	7	$114
Edwards Lifesciences	4	$86
Bridgebio Pharma, Inc.	2	$79
Pfizer	3	$78
Boehringer Ingelheim	3	$77
Cardiva Medical, Inc.	2	$51
AstraZeneca	2	$36
Kiniksa Pharmaceuticals International, PLC	1	$33
Cvrx, Inc.	1	$28
Johnson & Johnson	1	$28
Lexicon Pharmaceuticals, Inc.	1	$27
Merck	1	$23
Contego Medical, Inc	1	$19
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$18
Lilly USA, LLC	1	$18
Shockwave Medical, Inc	1	$17
Philips North America LLC	1	$16

Nirupama Krishnamurthi

Payments from drug & device makers

Who reported the general payments

What the payments were tied to